Node-negative

Node-negative means that when lymph nodes were examined (either by imaging, biopsy, or after surgical removal), no cancer cells were found in them. In staging shorthand it is written as "N0." For someone with mesothelioma or lung cancer, being node-negative generally indicates that the disease has not yet spread through the lymphatic system to nearby nodes.

Origin

The term comes from the TNM staging system developed by Pierre Denoix in France in the 1940s–1950s and later standardized by the Union for International Cancer Control (UICC) and the American Joint Committee on Cancer (AJCC). "N" refers to regional lymph node involvement, with N0 meaning no nodal disease detected.

Significance in Asbestos Context

For patients with pleural mesothelioma or asbestos-related lung cancer, lymph node status is one of the strongest predictors of prognosis and a major factor in deciding whether aggressive surgery (such as pleurectomy/decortication or extrapleural pneumonectomy) is appropriate. Node-negative patients are generally candidates for more curative-intent treatment, while node-positive disease often shifts the plan toward chemotherapy, immunotherapy, or radiation. In medical records, the N0 designation may appear in pathology reports, PET/CT readings, EBUS (endobronchial ultrasound) results, or mediastinoscopy reports, all of which can become important evidence in a legal claim because they document the stage and extent of disease at diagnosis.

Example Sentence

After her mediastinoscopy showed she was node-negative, her thoracic surgeon recommended proceeding with pleurectomy/decortication followed by chemotherapy.

Related Terms

TNM Staging, Mediastinoscopy, EBUS, Lymphadenopathy, Pleurectomy/Decortication, Mesothelioma Staging

Notes

• Ask your oncologist exactly how node status was determined. Imaging alone (PET/CT) is less definitive than tissue sampling via EBUS, mediastinoscopy, or surgical lymph node dissection.
• Request copies of pathology reports, operative notes, and staging summaries; the N0 designation and the number of nodes sampled should be clearly documented and may be needed by your legal team to establish disease stage at diagnosis.
• Node-negative status can change if more nodes are examined later during surgery; ask whether your stage is "clinical" (cN0, based on imaging/biopsy before surgery) or "pathologic" (pN0, confirmed after surgical removal), because the two carry different prognostic weight.
• For pleural mesothelioma specifically, ask whether both ipsilateral (same side) and contralateral (opposite side) mediastinal nodes were assessed. The distinction affects staging and treatment eligibility.